查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1966174

全球無針給藥裝置市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Needle-Free Drug Delivery Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

無針給藥裝置的市場規模預計將從 2025 年的 215.2 億美元成長到 2034 年的 434.5 億美元，2026 年至 2034 年的複合年成長率為 8.12%。

由於人們越來越關注針刺傷和傳統注射帶來的不適，全球無針給藥裝置市場正經歷顯著成長。包括噴射注射器和經皮吸收貼片在內的無針技術，為疫苗接種和慢性病管理提供了更安全、更方便的替代方案。疫苗接種計劃的擴展以及人們對微創手術日益成長的偏好，進一步推動了市場成長。

關鍵成長要素包括藥物傳遞系統的技術進步以及糖尿病等慢性疾病盛行率的上升。患者依從性的提高和交叉感染風險的降低增強了這些設備的吸引力。政府推廣疫苗接種的措施以及生物製藥和自我給藥療法的進步也促進了全球需求的成長。

未來前景依然光明，主要得益於生物製藥和大分子藥物應用拓展研究的不斷深入。與穿戴式科技和智慧給藥系統的融合可望進一步提升用藥便利性。儘管高成本和監管方面的挑戰可能構成一定障礙，但持續的技術創新有望推動市場普及，並支撐其長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球無針給藥裝置市場：依技術分類

  • 市場分析、洞察與預測
  • 吸入器技術
  • 經皮吸收貼片技術
  • 一種新型無針技術

第5章：全球無針給藥裝置市場：依應用分類

  • 市場分析、洞察與預測
  • 疫苗接種
  • 疼痛管理
  • 用於糖尿病治療的胰島素給藥系統
  • 兒童注射
  • 其他

第6章：全球無針給藥裝置市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • PenJet
    • Zealand Pharma
    • UCB SA
    • PharmaJet
    • 3M
    • Verdict Media Limited
    • INJEX Pharma AG
    • Antares Pharma
    • Endo Pharmaceuticals Inc
    • Bioject Medical TechnologiesInc
    • Crossject SA
簡介目錄
Product Code: VMR11210511

The Needle-Free Drug Delivery Devices Market size is expected to reach USD 43.45 Billion in 2034 from USD 21.52 Billion (2025) growing at a CAGR of 8.12% during 2026-2034.

The Global Needle-Free Drug Delivery Devices Market has grown significantly due to increasing concerns over needle-stick injuries and patient discomfort associated with traditional injections. Needle-free technologies, including jet injectors and transdermal patches, provide safer and more convenient alternatives for vaccine administration and chronic disease management. Rising vaccination programs and growing preference for minimally invasive procedures have further fueled market expansion.

Major growth drivers include technological advancements in drug delivery systems and the rising prevalence of chronic diseases such as diabetes. Improved patient compliance and reduced risk of cross-contamination enhance the appeal of these devices. Government initiatives promoting immunization and advancements in biologics and self-administration therapies also contribute to increasing demand globally.

Future prospects remain promising as research focuses on expanding applications for biologics and large-molecule drugs. Integration with wearable and smart drug delivery systems may further enhance usability. While high device costs and regulatory challenges may pose barriers, continuous innovation is expected to strengthen adoption and support long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Inhaler Technology
  • Transdermal Patch Technology
  • Novel Needle-Free Technologies

By Application

  • Vaccine Delivery
  • Pain Management
  • Insulin Delivery for Diabetes
  • Pediatric Injections
  • Others

COMPANIES PROFILED

  • PenJet, Zealand Pharma, UCB SA, PharmaJet, 3M, Verdict Media Limited, INJEX Pharma AG, Antares Pharma, Endo Pharmaceuticals Inc, Bioject Medical Technologies, Inc, Crossject SA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Inhaler Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Transdermal Patch Technology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Novel Needle-Free Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Vaccine Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Insulin Delivery for Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Pediatric Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Technology
    • 6.2.2 By Application
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Technology
    • 6.3.2 By Application
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Technology
    • 6.4.2 By Application
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Technology
    • 6.5.2 By Application
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Technology
    • 6.6.2 By Application
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NEEDLE-FREE DRUG DELIVERY DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 PenJet
    • 8.2.2 Zealand Pharma
    • 8.2.3 UCB S.A
    • 8.2.4 PharmaJet
    • 8.2.5 3M
    • 8.2.6 Verdict Media Limited
    • 8.2.7 INJEX Pharma AG
    • 8.2.8 Antares Pharma
    • 8.2.9 Endo Pharmaceuticals Inc
    • 8.2.10 Bioject Medical TechnologiesInc
    • 8.2.11 Crossject SA